Literature DB >> 21990362

Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE).

Ding Xu1, Jeffrey Young, Danyin Song, Jeffrey D Esko.   

Abstract

In a proteomic search for heparan sulfate-binding proteins on monocytes, we identified HMGB1 (high mobility group protein B1). The extracellular role of HMGB1 as a cytokine has been studied intensively and shown to be important as a danger-associated molecular pattern protein. Here, we report that the activity of HMGB1 depends on heparan sulfate. Binding and competition studies demonstrate that HMGB1 interacts with CHO and endothelial cell heparan sulfate. By site-directed mutagenesis, we identified a loop region that connects the A-box and B-box domains of HMGB1 as responsible for heparan sulfate binding. HMGB1-induced Erk1/2 and p38 phosphorylation is abolished when endothelial heparan sulfate is removed or blocked pharmacologically, resulting in decreased HMGB1-induced endothelial sprouting. However, mutated HMGB1 that lacks the heparan sulfate-binding site retained its signaling activity. We show the major receptor for HMGB1, receptor for advanced glycation end products (RAGE), also binds to heparan sulfate and that RAGE and heparan sulfate forms a complex. Our data establishes that the functional receptor for HMGB1 consists of a complex of RAGE and cell surface heparan sulfate.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990362      PMCID: PMC3308882          DOI: 10.1074/jbc.M111.299685

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188.

Authors:  P Carmeliet; Y S Ng; D Nuyens; G Theilmeier; K Brusselmans; I Cornelissen; E Ehler; V V Kakkar; I Stalmans; V Mattot; J C Perriard; M Dewerchin; W Flameng; A Nagy; F Lupu; L Moons; D Collen; P A D'Amore; D T Shima
Journal:  Nat Med       Date:  1999-05       Impact factor: 53.440

Review 2.  Alarmin(g) news about danger: workshop on innate danger signals and HMGB1.

Authors:  Helena Erlandsson Harris; Angela Raucci
Journal:  EMBO Rep       Date:  2006-07-21       Impact factor: 8.807

3.  CHO glycosylation mutants: proteoglycans.

Authors:  Lijuan Zhang; Roger Lawrence; Beth A Frazier; Jeffrey D Esko
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

4.  Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.

Authors:  Stefania Mitola; Mirella Belleri; Chiara Urbinati; Daniela Coltrini; Bianca Sparatore; Marco Pedrazzi; Edon Melloni; Marco Presta
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 5.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.

Authors:  Michael T Lotze; Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2005-04       Impact factor: 53.106

6.  Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses.

Authors:  Lianchun Wang; Mark Fuster; P Sriramarao; Jeffrey D Esko
Journal:  Nat Immunol       Date:  2005-07-31       Impact factor: 25.606

7.  Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis.

Authors:  Lars Jakobsson; Johan Kreuger; Katarina Holmborn; Lars Lundin; Inger Eriksson; Lena Kjellén; Lena Claesson-Welsh
Journal:  Dev Cell       Date:  2006-05       Impact factor: 12.270

Review 8.  Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

Authors:  Giuseppina Basta
Journal:  Atherosclerosis       Date:  2007-09-10       Impact factor: 5.162

9.  Structure of a complex of tandem HMG boxes and DNA.

Authors:  Katherine Stott; George S F Tang; Keng-Boon Lee; Jean O Thomas
Journal:  J Mol Biol       Date:  2006-05-12       Impact factor: 5.469

10.  Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis.

Authors:  Mark M Fuster; Lianchun Wang; Janice Castagnola; Lyudmila Sikora; Krisanavane Reddi; Phillip H A Lee; Katherine A Radek; Manuela Schuksz; Joseph R Bishop; Richard L Gallo; P Sriramarao; Jeffrey D Esko
Journal:  J Cell Biol       Date:  2007-04-30       Impact factor: 10.539

View more
  40 in total

1.  Continuous hemodiafiltration therapy reduces damage of multi-organs by ameliorating of HMGB1/TLR4/NFκB in a dog sepsis model.

Authors:  Jing Sun; Shaolan Shi; Qun Wang; Kezhou Yu; Rong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  THE GLYCOCALYX AND TRAUMA: A REVIEW.

Authors:  Andreia Z Chignalia; Feliz Yetimakman; Sarah C Christiaans; Sule Unal; Benan Bayrakci; Brant M Wagener; Robert T Russell; Jeffrey D Kerby; Jean-Francois Pittet; Randal O Dull
Journal:  Shock       Date:  2016-04       Impact factor: 3.454

Review 3.  The Role of HMGB1, a Nuclear Damage-Associated Molecular Pattern Molecule, in the Pathogenesis of Lung Diseases.

Authors:  Mao Wang; Alex Gauthier; LeeAnne Daley; Katelyn Dial; Jiaqi Wu; Joanna Woo; Mosi Lin; Charles Ashby; Lin L Mantell
Journal:  Antioxid Redox Signal       Date:  2019-07-11       Impact factor: 8.401

Review 4.  Danger-Associated Molecular Patterns Derived From the Extracellular Matrix Provide Temporal Control of Innate Immunity.

Authors:  Charles W Frevert; Jessica Felgenhauer; Malgorzata Wygrecka; Madalina V Nastase; Liliana Schaefer
Journal:  J Histochem Cytochem       Date:  2018-01-01       Impact factor: 2.479

5.  Tannerella forsythia-produced methylglyoxal causes accumulation of advanced glycation endproducts to trigger cytokine secretion in human monocytes.

Authors:  R P Settem; K Honma; M Shankar; M Li; M LaMonte; D Xu; R J Genco; R W Browne; A Sharma
Journal:  Mol Oral Microbiol       Date:  2018-05-02       Impact factor: 3.563

6.  Proteomics-based screening of the endothelial heparan sulfate interactome reveals that C-type lectin 14a (CLEC14A) is a heparin-binding protein.

Authors:  Daniel R Sandoval; Alejandro Gomez Toledo; Chelsea D Painter; Ember M Tota; M Osman Sheikh; Alan M V West; Martin M Frank; Lance Wells; Ding Xu; Roy Bicknell; Kevin D Corbett; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2020-01-21       Impact factor: 5.157

7.  Immunoaffinity-Based Liquid Chromatography Mass Spectrometric Assay to Accurately Quantify the Protein Concentration of HMGB1 in EDTA Plasma.

Authors:  Viktoria Anselm; Andreas Steinhilber; Cornelia Sommersdorf; Oliver Poetz
Journal:  Methods Mol Biol       Date:  2021

8.  Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis.

Authors:  Pengfei Li; Grant Bledsoe; Zhi-Rong Yang; Hongkuan Fan; Lee Chao; Julie Chao
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

9.  Stable RAGE-heparan sulfate complexes are essential for signal transduction.

Authors:  Ding Xu; Jeffrey H Young; Juno M Krahn; Danyin Song; Kevin D Corbett; Walter J Chazin; Lars C Pedersen; Jeffrey D Esko
Journal:  ACS Chem Biol       Date:  2013-05-28       Impact factor: 5.100

10.  The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus.

Authors:  Sean P Durning; Paula Preston-Hurlburt; Paul R Clark; Ding Xu; Kevan C Herold
Journal:  J Immunol       Date:  2016-09-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.